Financial Year |
March 31 2023 |
Monetary Funds |
63,232,175,227.08 |
Held-for-trading Financial Assets |
1,707,245,778.25 |
Notes Receivable |
1,769,014,697.50 |
Accounts Receivable |
47,953,473,382.44 |
Advances to Suppliers |
2,409,289,624.80 |
Other Receivables |
7,185,149,307.53 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
35,000,000.00 |
Inventories |
64,806,333,740.56 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
538,605,889.60 |
Other Current Assets |
4,484,363,656.18 |
Total Current Assets |
248,157,904,012.80 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
21,696,274,607.09 |
Long-term Equity Investment |
8,528,278,037.91 |
Investment Properties |
4,358,056,173.97 |
Fixed Assetes |
8,559,493,256.09 |
Under-construction Projects |
1,154,046,765.23 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
4,240,026,893.20 |
R&D expenses |
-- |
Goodwill |
467,570,230.79 |
Long-Term Deferred and Prepaid Expenses |
494,610,273.94 |
Deferred Income Tax Assets |
1,688,090,013.04 |
Other Non-Current Assets |
28,964,265,089.79 |
Sub-Total of Non-Current Assets |
88,023,441,809.19 |
Total Assets |
336,181,345,821.99 |
Short-Term Loans |
9,322,958,281.14 |
Trading Financial liabilities |
-- |
Notes Payable |
13,986,756,396.07 |
Accounts Payable |
125,360,583,009.04 |
Accounts Received In Advance |
79,393,389.09 |
Employee Compensation Payable |
464,905,194.77 |
Taxes Payable |
3,473,778,676.03 |
Interest Payable |
-- |
Dividend Payable |
18,526,688.63 |
Other payables |
20,574,112,347.10 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
8,150,440,335.27 |
Other Current Liabilities |
736,234,568.45 |
Sub-Total of Current Liabilities |
211,910,820,058.82 |
Long-term Loans |
62,327,683,969.66 |
Bonds Payable |
6,107,019,071.73 |
Long-Term Accounts Payable |
1,282,588,007.72 |
Special Payable |
-- |
Estimatied Liabilities |
50,936,272.17 |
Deferred Income Tax Liabilities |
450,517,096.75 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
73,138,424,416.57 |
Total Liabilities |
285,049,244,475.39 |
Paid-In Capital(Or Share Stock) |
8,904,397,728.00 |
Capital Surplus |
2,791,426,196.65 |
Surplus Reserve |
2,427,202,402.86 |
LESS:Treasury Stock |
63,704,768.29 |
Undistributed Profits |
16,194,757,230.04 |
Minority Stockholder's Interest |
10,538,215,038.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
40,593,886,308.60 |
Owner's Equity(Stockholder's Equity) |
51,132,101,346.60 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
336,181,345,821.99 |